The 3-month cumulative incidence of mortality was 21.4% in patients with both the absence of LC3 and hypoalbuminemia, compared to only 0.4% among those with both the presence of LC3 and serum albumin levels ≥ 3.5 g/dl. Here, MAP1LC3A is linked to Hypoalbuminemia.